| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9725 |
| Human Intestinal Absorption | HIA+ | 0.9687 |
| Caco-2 Permeability | Caco2+ | 0.6957 |
| P-glycoprotein Substrate | Non-substrate | 0.8877 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9732 |
| Non-inhibitor | 0.9855 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9154 |
| Distribution |
| Subcellular localization | Lysosome | 0.4862 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8289 |
| CYP450 2D6 Substrate | Non-substrate | 0.8233 |
| CYP450 3A4 Substrate | Non-substrate | 0.8075 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8726 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9266 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9657 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9452 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9803 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8881 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9489 |
| Non-inhibitor | 0.9737 |
| AMES Toxicity | Non AMES toxic | 0.9503 |
| Carcinogens | Carcinogens | 0.6480 |
| Fish Toxicity | Low FHMT | 0.6535 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6398 |
| Honey Bee Toxicity | High HBT | 0.8474 |
| Biodegradation | Ready biodegradable | 0.8278 |
| Acute Oral Toxicity | III | 0.6385 |
| Carcinogenicity (Three-class) | Non-required | 0.4650 |